Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04775537 · ClinicalTrials.gov registry record
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
A clinical trial of Degenerative Disc Disease and Spinal Disease, sponsored by Collagen Matrix.
- Recruiting
- Registry status
- 120
- Enrollment target
- 4
- Study locations
NCT04775537: Recruiting study of Degenerative Disc Disease and Spinal Disease, sponsored by Collagen Matrix.
NCT04775537 is a study of Degenerative Disc Disease and Spinal Disease that is actively recruiting participants, run by Collagen Matrix. The registered enrollment target is 120 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (28% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04775537, a study of Degenerative Disc Disease and Spinal Disease, is actively recruiting participants, sponsored by Collagen Matrix.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
Primary Outcome
Fusion will be assessed with A/P and Lateral radiographs taken and scored with Lenke's classification of posterolateral fusion success
Conditions Studied
Interventions
- DEVICE OssiMend™ Bioactive Moldable
Study Locations (4)
California
- San Diego Neurosurgery - Encinitas
Connecticut
- Hartford Hospital - Hartford
New Jersey
- University Orthopaedic Associates, Division of OrthoNJ - Somerset
Oregon
- McKenzie-willamette Medical Center - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2027-01-30 |
What NCT04775537 shows while recruiting
NCT04775537 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (28% lower).
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which OssiMend™ Bioactive Moldable is the first listed.
NCT04775537 reports a single indexed study location in California, Connecticut, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04775537 about?
NCT04775537 is a clinical study titled "OssiMend BA in Posterolateral Instrumented Lumbar Fusion". The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
What is the current status of trial NCT04775537?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2021-01-21. Estimated completion is 2027-01-30.
What conditions does trial NCT04775537 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Spinal Disease.
What interventions are being tested in trial NCT04775537?
The interventions under investigation include: OssiMend™ Bioactive Moldable (DEVICE).
Who is sponsoring clinical trial NCT04775537?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04775537 being conducted?
This trial has 4 study locations across California, Connecticut, New Jersey, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04775537's enrollment target sits among peer trials
120 19th of 42 higher than 24 of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI